Cognitive Impairment in Older Emergency Department Users and Associated Adverse Outcomes
1 other identifier
observational
4,724
1 country
1
Brief Summary
This study examines the prevalence and incidence of older ER users with cognitive impairment (i.e., dementia and/or delirium) using the ER2 item temporal disorientation in older ED users who are participants of the ER2 cohort study database.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 17, 2020
CompletedStudy Start
First participant enrolled
January 17, 2020
CompletedFirst Posted
Study publicly available on registry
January 22, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2025
CompletedFebruary 23, 2024
February 1, 2024
2 years
January 17, 2020
February 22, 2024
Conditions
Outcome Measures
Primary Outcomes (5)
Length of hospital stay
The length of hospital stay is defined as the average number of days that patients spend in hospital. It will be used the ER2 tool ( Emergency Room Evaluation and Recommendation) to calculate the length of hospital stay.
12 months
Dementia
The diagnosis of dementia
12 months
Delirium
The diagnosis of delirium
12 months
Length of stay in ED
The length of ED stay is defined as the average number of days that patients spend in the ED. It will use the ER2 tool ( Emergency Room Evaluation and Recommendation) to calculate the length of ED stay.
12 months
Hospital admission rate
The number of individuals admitted to the hospital
12 months
Interventions
ER2 is a simple and standardized clinical tool. The results of the questionnaires performed in ER2 study will be used. The assessment component of ER2 consists of 6 very simple closed-ended format questions (i.e., yes versus no) which are: Age category (≥ 85), male, polypharmacy (≥ 5 different medications per day), use of formal (health care or social professional) and/or informal (family and/or friend) home support, use of a walking aid regardless of its type, and temporal disorientation (inability to give the current month and/or year). A score of five points is assigned to the items "use of walking aid" and "temporal disorientation", whereas, for the other items, the assigned score is one point. The weighting of points for ER2 items is based on the results of our previous studies. Scores range from 0 (lowest risk) to 14 (highest risk). ER2 scores stratify the risk for short-term ED adverse events into three levels: low, moderate and high.
Eligibility Criteria
Individuals eligible for this study are the participants in the ER2 study.
You may qualify if:
- \- An unplanned ED visit and to be on a stretcher
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jewish General Hospital
Montreal, Quebec, H3T 1E2, Canada
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD, Professor of Geriatrics, Holder of the Dr. Joseph Kaufmann Chair in Geriatric Medicine Clinician Scientist, Department of Medicine, Division of Geriatric Medicine Director of Centre of Excellence on Longevity, RUISSS McGill, McGill University
Study Record Dates
First Submitted
January 17, 2020
First Posted
January 22, 2020
Study Start
January 17, 2020
Primary Completion
February 1, 2022
Study Completion
February 1, 2025
Last Updated
February 23, 2024
Record last verified: 2024-02